IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Dr Lalchandani Labs IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 4.20 Cr. The company is based in New Delhi and caters to Healthcare sector. Navigant Corporate Advisors is the merchant banker of Dr Lalchandani Labs IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd February 2018.
Dr Lalchandani Labs IPO posted revenues of ₹ 2.57 crores and PAT of ₹ 0.29 crores in FY18 on annualised basis.
Revenue:
₹ 2.57 Cr.
EBITDA Margin:
24.77
% 
Net Worth: ₹ 3.29 Cr.
Market Capitalisation:
[●]
P/E:
10.00 times
P/BV: [●]
EV/EBITDA: [●]
Financial results of Dr Lalchandani Labs IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Jan-18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 6.02 | 3.76 | 3.66 | 1.87 | |
| Net Worth | 3.29 | [●] | [●] | [●] | |
| Total Debt | 1.50 | 1.71 | 1.76 | 1.54 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
2.14
2.57 |
4.52 | 3.02 | 1.90 | |
EBITDA
EBITDA on annualised basis |
0.53
0.64 |
1.22 | 0.79 | 0.51 | |
PAT
PAT on annualised basis |
0.24
0.29 |
0.70 | 0.32 | 0.31 | |
Dr Lalchandani Labs IPO PAT Margin is 11.21 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Dr Lalchandani Labs IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Jan-18 | FY17 | FY16 | FY15 |
|---|---|---|---|---|
| EBITDA Margin (%) | 24.77 | 26.99 | 26.16 | 26.84 |
| PAT Margin (%) | 11.21 | 15.49 | 10.60 | 16.32 |
| EPS (₹) | 1.01 | [●] | [●] | [●] |
| ROE (%) | 7.29 | [●] | [●] | [●] |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 3.99 | 18.62 | 8.74 | 16.58 |
| Debt to Equity | 0.46 | [●] | [●] | [●] |
The market Capitalisation of Dr Lalchandani Labs IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Dr Lalchandani Labs IPO prospectus highlights an Return on Equity (ROE) of 7.29 % , Return on Assets (ROA) of 3.99 %, and an EBITDA Margin of 24.77 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Dr Lalchandani Labs IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Dr Lalchandani Labs IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Dr Lalchandani Labs IPO has a Price-to-Earnings (PE) ratio of 10.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Dr Lalchandani Labs IPO reported revenue of ₹ 2.57 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Dr Lalchandani Labs IPO provide insights into sales growth, market demand, and business scalability.
Dr Lalchandani Labs recorded an EBITDA of ₹ 0.64 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Dr Lalchandani Labs Profit After Tax (PAT) is ₹ 0.29 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 2.57 Cr.
EBITDA Margin:
24.77
%
Net Worth: ₹ 3.29 Cr.
Market Capitalisation:
[●]
P/E:
10.00 times
P/BV: [●]
EV/EBITDA: [●]
Dr Lalchandani Labs operates in Healthcare and Provider Of Diagnostic And Related Healthcare Tests. The Issue is listed on BSE SME in May, 2018. Dr Lalchandani Labs IPO size was 4.20 with Issue price of 30.00 .
Merchant Banker(s) of Dr Lalchandani Labs IPO: Navigant Corporate Advisors Limited
Dr Lalchandani Labs IPO subscription was 4.96 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Dr Lalchandani Labs IPO listed at a listing price of 28.50 against the offer price of 30.00.
The current market price of Dr Lalchandani Labs is 19.39.
Why Us?
